Marieke van Rosmalen

Chapter 2 38 concurrent validity of three Dutch self-report questionnaires. Disabil. Rehabil. 2010;32:1870– 1876. 20. Krupp L, LaRocca N, Muir-Nash J, Steinberg A. The Fatigue Severity Scale: application to patients with Multiple Sclerosis and Systemic Lupus Erythematosus. Arch Neurol 1989;46:1121–1123. 21. Martina ISJ, Van Koningsveld R, Schmitz PIM, et al. Measuring vibration threshold with a graduated tuning fork in normal aging and in patients with polyneuropathy. J. Neurol. Neurosurg. Psychiatry 1998;65:743–747. 22. Van Den Berg-Vos RM, Franssen H, Wokke JHJ, Van Den Berg LH. Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment. Brain 2002;125:1875– 1886. 23. Van Asseldonk JTH, Van den Berg LH, Van den Berg-Vos RM, et al. Demyelination and axonal loss in multifocal motor neuropathy: Distribution and relation to weakness. Brain 2003;126:186–198. 24. Al-Zuhairy A, Sindrup SH, Andersen H, Jakobsen J. A population-based and cross- sectional study of the long-term prognosis in multifocal motor neuropathy. J. Peripher. Nerv. Syst. 2019;24:64–71. 25. Cats EA, Jacobs BC, Yuki N, et al. Multifocal motor neuropathy: Association of anti-GM1 IgM antibodies with clinical features. Neurology 2010;75:1961–1967. 26. Vlam L, Cats EA, Harschnitz O, et al. Complement activity is associated with disease severity in multifocal motor neuropathy. Neurol. Neuroimmunol. NeuroInflammation 2015;2:1– 8. 27. Van Alfen N, Van Engelen BGM. The clinical spectrum of neuralgic amyotrophy in 246 cases. Brain 2006;129:438–450. 28. Merkies ISJ, Faber CG. Fatigue in immune- mediated neuropathies. Neuromuscul. Disord. 2012;22:S203–S207. 29. Merkies IS, Schmitz PI, Samijn JP, et al. Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Neurology 1999;53:1648–54. 30. Kobayashi C, Miyazaki D, Kinoshita T, et al. Increasing Incidence and Age at Onset of Amyotrophic Lateral Sclerosis in Nagano Prefecture, Japan. Shinshu Med J 2016;64:239– 246. 31. Delmont E, Benaïm C, Launay M, et al. Do patients having a decrease in SNAP amplitude during the course of MMN present with a different condition? J. Neurol. 2009;256:1876– 1880. 32. Lambrecq V, Krim E, Rouanet-Larrivière M, Lagueny A. Sensory loss in multifocal motor neuropathy: a clinical and electrophysiological study. Muscle and Nerve 2009;39:131–136.